Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
08/07/2002 | EP1228039A1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
08/07/2002 | EP1227722A1 Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
08/07/2002 | EP1107949A4 Process for preparing certain phenyl urea compounds |
08/07/2002 | EP0839143B1 Tetralin compounds with mdr activity |
08/07/2002 | EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
08/07/2002 | EP0770599B1 Process for the preparation of aromatic or heteroaromatic sulfonyl halides |
08/07/2002 | EP0638112B1 Liquid crystal compounds having perfluoroether terminal portions |
08/07/2002 | CN1362959A C10 carbamoyloxy substituted taxanes as antitumor agents |
08/07/2002 | CN1362958A C7 carbonate substituted taxanes as antitumor agents |
08/07/2002 | CN1362951A Dihetero-substituted metalloprotease inhibitors |
08/07/2002 | CN1362948A Process of preparing 3S-3-amino-3-acryl propionic acid and derivatives thereof |
08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
08/07/2002 | CN1362884A Preventives/remedies for liver diseases |
08/07/2002 | CN1088699C Preparation method for chlormethyl pyridine compound |
08/06/2002 | US6429330 Process for producing carbocyclic nitriles |
08/06/2002 | US6429317 Indane derivatives for antipsychotic compositions |
08/06/2002 | US6429213 Cyclic hydroxamic acids as metalloproteinase inhibitors |
08/06/2002 | US6429207 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
08/06/2002 | US6429206 Using agonist of nicotinergic acetylcholine receptors |
08/06/2002 | US6428780 Modified amino acid |
08/01/2002 | WO2002059215A1 Azo dyes, a process for their preparation and their use in the production of coloured plastics or polymeric colour particles, and in the dyeing or printing of hydrophobic fibre materials |
08/01/2002 | WO2002059093A1 Methods and compositions for binding nucleic acid molecules |
08/01/2002 | WO2002059086A1 Carboxamides as fungicides in agriculture |
08/01/2002 | WO2002059080A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use |
08/01/2002 | WO2002059077A1 Aminoethanol derivatives |
08/01/2002 | WO2002059074A1 Benzylamine analogue |
08/01/2002 | WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
08/01/2002 | WO2002058658A1 Primary intermediates for oxidative coloration of hair |
08/01/2002 | WO2002058654A1 Primary intermediates for oxidative coloration of hair |
08/01/2002 | WO2002058653A1 Primary intermediates for oxidative coloration of hair |
08/01/2002 | WO2002058631A2 Primary intermediates for oxidative coloration of hair |
08/01/2002 | WO2002040431A3 Compounds having fungicidal activity and processes to make and use same |
08/01/2002 | WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands |
08/01/2002 | WO2002008190A3 Novel heteroaryl derivatives and use thereof as anti-tumour agents |
08/01/2002 | US20020103387 Compounds which mimic the chemical and biological properties of discodermolide |
08/01/2002 | US20020103379 Making 2,2-difluoro-2-(2-pyridyl)-ethan-1-ol, by coupling 2-bromopyridine with ethyl 2-bromo-2,2-difluoroacetate, using metallic copper and solvent; chemical intermediates |
08/01/2002 | US20020103256 Contacting helminth, nematode, insect or acarid pests or parasites or their food supply, habitat or breeding grounds with a nitroethyl derivative |
08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
08/01/2002 | US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same |
08/01/2002 | US20020103228 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications |
08/01/2002 | US20020103227 Nitric oxide synthase inhibitors such as 6(4'-(4-phenethyl-piperazin-1-ylmethyl)-biphenyl-4-yl)-pyridin-2-ylamine for treatment and prevention of central nervous system disorders |
08/01/2002 | US20020103217 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids |
08/01/2002 | US20020103203 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis |
08/01/2002 | US20020103194 Secondary amine, imine, amidine, guanidine, or other nitrogen functional group compounds; for treatment or prevention of diseases in which treatment is mediated by muscarinic receptor agonism such as cognitive decline and Alzheimer's disease |
08/01/2002 | US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone |
08/01/2002 | US20020103190 Azo amino acids derivatives |
08/01/2002 | US20020103168 Fungicide phenylimine derivatives |
08/01/2002 | US20020103164 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
08/01/2002 | US20020103071 Olefin polymerization catalyst system includes an activator, and a catalyst compound comprising a transition metal complexed with facially coordinating tridentate bisamide ligand |
08/01/2002 | US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization |
08/01/2002 | US20020100732 For removing metals from soils, water; pollution control; form stable, irreversible ligand-metal precipitates |
08/01/2002 | US20020100126 Novel coupler for use in oxidative hair dyeing |
08/01/2002 | CA2435883A1 Benzylamine analogue |
08/01/2002 | CA2435829A1 Trisubstituted carbocyclic cyclophilin binding compounds and their use |
08/01/2002 | CA2434311A1 4-amino-2-(1-aryloxy-ethyl)phenol compounds as primary intermediates for oxydative coloration of hair |
08/01/2002 | CA2433819A1 Carboxamides as fungicides in agriculture |
08/01/2002 | CA2433686A1 Primary intermediates for oxidative coloration of hair |
08/01/2002 | CA2431611A1 Primary intermediates for oxidative coloration of hair |
07/31/2002 | EP1227092A2 Isonitrile intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
07/31/2002 | EP1227091A2 Formamide intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
07/31/2002 | EP1226138A1 Fab i inhibitors |
07/31/2002 | EP1226127A2 Uracil substituted phenyl sulfamoyl carboxamides |
07/31/2002 | EP1225955A1 Aryl olefinic azacyclic, and aryl acetylenic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
07/31/2002 | EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
07/31/2002 | EP0946473B1 Fluorinated phenantrene derivatives for liquid crystal mixtures |
07/31/2002 | EP0944565B1 1,3,5-trifluoronaphthalene derivatives for liquid crystalline mixtures |
07/31/2002 | EP0748160B1 Process for preparing copper pyrithione |
07/31/2002 | CN1361768A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
07/31/2002 | CN1361766A Tricyclic compounds bearing acyloxymethoxy-carbonyl pendants |
07/31/2002 | CN1361687A Phosphate transport inhibitors |
07/31/2002 | CN1360890A Use of active retiene derivative with negative hormone and/or antagonist |
07/31/2002 | CN1088459C 1,4-disubstituted piperazines |
07/31/2002 | CA2369462A1 Nicotinamide acids, amides, and their mimetics active as inhibitors of pde4 isozymes |
07/30/2002 | US6426418 Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide |
07/30/2002 | US6426366 Pharmaceutical compositions comprising tyrphostins |
07/30/2002 | US6426365 CETP activity inhibitors |
07/30/2002 | US6426354 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
07/30/2002 | US6426349 Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia |
07/30/2002 | US6426348 For therapy of inflammation associated with chronic inflammatory diseases such as rheumatoid arthritis (ra), multiple sclerosis, (ms), asthma, and inflammatory bowel disease (i bd) |
07/30/2002 | US6426346 Anticoagulants |
07/25/2002 | WO2002057492A1 Methods and compositions for detecting polynucleotide duplex damage |
07/25/2002 | WO2002057422A2 Ternary biomolecule/polymer/surface-based immobilization systems |
07/25/2002 | WO2002057370A1 Dispers-reactive dyes containing acetoxymethylsulfone or vinylsulfone and their process |
07/25/2002 | WO2002057242A2 Urea derivatives as integrin alpha 4 antagonists |
07/25/2002 | WO2002057237A1 Hetero-tricyclic compounds having substituted amino groups |
07/25/2002 | WO2002057236A1 Phenyl derivatives |
07/25/2002 | WO2002057233A1 Mch antagonists and their use in the treatment of obesity |
07/25/2002 | WO2002057220A1 Hydrazide derivatives and pharmaceutical compositions containing same |
07/25/2002 | WO2002057219A1 Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
07/25/2002 | WO2002057216A1 Terphenyl compounds bearing substituted amino groups |
07/25/2002 | WO2002057215A2 Sodium channel modulators |
07/25/2002 | WO2002057211A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
07/25/2002 | WO2002057199A1 Process for a homogeneously catalyzed c-c coupling reaction |
07/25/2002 | WO2002056889A1 Method of synthesis of chromium amino acid nicotinate complex |
07/25/2002 | WO2002056827A2 Substituted felbamate derived compounds |
07/25/2002 | WO2002032874A3 Substituted heterocyclic compounds for treating multidrug resistance |
07/25/2002 | WO2002032845A3 Method of producing carboxylic acid salts |
07/25/2002 | WO2002028805A3 Process for the co-oligomerisation of ethylene and alpha olefins |
07/25/2002 | WO2002015884A3 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
07/25/2002 | WO2002008177A3 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |